iSpecimen Inc. (ISPC)
| Market Cap | 1.92M |
| Revenue (ttm) | 9.93M |
| Net Income (ttm) | -11.10M |
| Shares Out | 9.09M |
| EPS (ttm) | -1.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 99,373 |
| Open | 0.231 |
| Previous Close | 0.227 |
| Day's Range | 0.210 - 0.232 |
| 52-Week Range | 0.200 - 2.046 |
| Beta | 1.69 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 2, 2024 |
About ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketp... [Read more]
Financial Performance
In 2023, iSpecimen's revenue was $9.93 million, a decrease of -4.56% compared to the previous year's $10.40 million. Losses were -$11.10 million, 8.33% more than in 2022.
Financial StatementsNews
iSpecimen Reports Full Year 2023 Results
LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after th...
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Servi...
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medic...
iSpecimen Strengthens Global Oncology Biospecimen Offering
Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research Adds New Suppliers and Expands Existing R...
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives Sequential Quarterly Revenue Growth of 75% Drive...
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Comple...
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023 Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical Research Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Med...
iSpecimen Expands Provider Network to Enhance Support for Women's Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIs ...
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions Company to Focus on Core Revenue Drivers, New Re...
Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program
Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutati...
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and Facilitate Automated, Instant Matchmaking for Researcher Requests New Capabilities Enable Plat...
iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers
Company Continues to Enhance the Biospecimen Procurement Process and Provide Increasingly Robust Specimen and Patient Data Company Continues to Enhance the Biospecimen Procurement Process and Provide ...
iSpecimen Reports Second Quarter 2023 Financial and Operating Results
LEXINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medi...
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023
LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medi...
Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network
Network's Expansion Across the U.S. and Europe Aims to Advance Translational Genomics Research Network's Expansion Across the U.S. and Europe Aims to Advance Translational Genomics Research
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with ...
iSpecimen Reports First Quarter 2023 Results
LEXINGTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medica...
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023
LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for me...
iSpecimen to Report First Quarter 2023 Results on May 4, 2023
LEXINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for med...
iSpecimen Reports Full Year 2022 Results
- Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year - - Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year -
iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023
LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medi...